|
Steinfeld S D, Tant L, Burmester G R. Epratuzumab (humanised anti-CD22 antibody) in primary Sj-gren's syndrome:an open-label phase I/II study [J]. Arthritis Research & Therapy, 2006.129.doi: 10.1186/ar2018.
|
|
Harris E D, Budd R C, Firestein G S. 凯利风湿病学 [M]. 北京:人民卫生出版社, 2006.944.
|
|
Golstein M A, Steinfeld S. Ankylosing spondylitis with Sjogren′s syndrome:the first two case reports [J]. Rev Rhum Engl, 1998.434.
|
|
Gusis S E, Villa N G, Maldonado-Cocco J A. Sjogren's syndrome in seronegative spondylarthropathies:an unusual finding [J]. Arthritis and Rheumatism, 1994.771.
|
|
Brandt J, Rudwaleit M, Eggens U. Increased frequence of Sj-gren's syndrome in patients with spondylarthropathy [J]. Journal of Rheumatology, 1998.718.
|
|
Nicholas J, Sheehan MD FRCP. The ramifications of HLA-B27 [J]. Journal of the Royal Society of Medicine, 2004.10.
|
|
Posnet D N, Yarilin D. Amplification of autoimmune disease by infection [J]. Arthritis Research & Therapy, 2005(2):74.
|
|
Horiuchi M, Yamano S, Inoue H. Possible involvement of IL-12 expression by Epstein-Barr virus in Sjogren syndrome [J]. Journal of Clinical Pathology, 1999.833.doi: 10.1136/jcp.52.11.833.
|
|
Lee S H, Lee Y A, Woo D H. Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean [J]. Arthritis Research & Therapy, 2006(6):1186.
|
|
Simard N, Boire G, Brum-Fernandes A J. A novel approach to measure the contribution of matrix metalloproteinase in the overall net proteolytic activity present in synovial fluids of patients with arthritis [J]. Arthritis Research & Therapy, 2006(4):186.
|
|
Mahmoodi M, Sahebjam S, Smookler D. Lack of Tissue Inhibitor of Metalloproteinases-3 Results in an Enhanced Inflammatory Response in Antigen-Induced Arthritis [J]. American Journal of Pathology, 2005(6):1733.
|
|
Ittah M, Miceli-Richard C, Gottenberg J E. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sj gren's syndrome [J]. Arthritis Research & Therapy, 2006.R51.
|
|
Willeke P, Gaubitz M, Schotte H. Increased serum levels of macrophage migration inhibitory factor in patients with primary Sj gren's syndrome [J]. Arthritis Research & Therapy, 2007.R43.
|
|
Trousdale M D, Zhu Z, Stevenson D. Expression of TNF inhibitor gene in the lacrimal gland promotes recovery of tear production and tear stability and reduced immunopathology in rabbits with induced autoimmune dacryoadenitis [J]. Journal of Autoimmune Diseases, 2005.6.doi: 10.1186/1740-2557-2-6.
|
|
Michele Bombardieri M, Barone F, Pittoni V. Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sj-gren′s syndrome:relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate [J]. Arthritis Research & Therapy, 2004(5):447.
|
|
Douni E, Sfikakis P P, Haralambous S. Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein:comparative analysis with dexamethasone, methotrexate and anti-TNF protocols [J]. Arthritis Research & Therapy, 2004(1):65.
|
|
Kitaura H, Zhou P, Kim H J. M-CSF mediates TNF-induced inflammatory osteolysis [J]. Journal of Clinical Investigation, 2005, (12):3418.doi: 10.1172/JCI26132.
|
|
Baraliakos X, Listing J, Brandt J. Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab [J]. Arthritis Research & Therapy, 2005(3):439.
|
|
Braun J, Sieper J. Therapy of ankylosing spondylitis and other pondyloarthritides:established medical treatment, anti-TNF-α therapy and other novel approaches [J]. Arthritis Research, 2002(5):307.
|
|
Bosch F V, Keyser F D, Mielants H. Tumor necrosis factor-α blockade in ankylosing spondylitis:a potent but expensive anti-inflammatory treatment or true disease modification [J]. Arthritis Research & Therapy, 2005(3):121.
|
|
Drouart M, Saas P, Billot M. High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003.158.
|
|
丁健. 类风湿关节炎合并骶髂关节改变患者临床特点分析 [J]. 中华风湿病学杂志, 2005, (2):105.doi: 10.3760/j:issn:1007-7480.2005.02.013.
|
下载:
苏公网安备 32100302010246号
